Slide 1: Exchange filing cover letter for investor presentation
PII) LIMITE,I) Manufacturers and Suppliers of Male & Female Condoms u## Date: - 27th May,2023 To, Department of Corporate Services, The National Stock Exchange of lndia Ltd. BSE LIMITED, Exchange Plaza, Sth Floor, Bandra-Kurla Phiroze Jeejeebhoy Towers, Complex, Bandra (East), Dalal Street, Mumbai -
Slide 2: Cupid Limited Investor Presentation Q4 FY23
Cupid Limited Investor Presentation Q4 FY23
Slide 3: Safe Harbour Statement
Safe Harbour Statement This presentation and the accompanying slides (the “Presentation”), which have been prepared by Cupid Limited (Cupid, The Company) solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and sha
Slide 4: Company Overview
Company Overview
Slide 5: Cupid @ Glance
Cupid @ Glance Established in 1993, CUPID Limited is India’s leading manufacturer of male and female condoms, water based lubricant jelly and IVD kits. The Company has presence in the international and domestic market and it is the 1st Company in the world to get WHO/UNFPA pre qualification for male
Slide 6: Our Vision
Our Vision CUPID’S VISION We at Cupid Limited are committed to play a promising role for the fight against HIV/AIDS & Prevention of Unintended Pregnancy. Developing a safe and effective methodology against HIV is critical to our efforts to control the devastating pandemic of HIV/AIDS as WE HELP THE
Slide 7: Key Facts And Figures
Key Facts And Figures Over 2 decades Presence in 90+ First Company to have World class German technology for of experience countries WHO/UNFPA manufacturing factory condom manufacturing Prequalification for both spread over 1,00,000 Male & Female Condoms Sq. Feet Strong export Active In-house R&D St
Slide 8: From Humble Beginnings to Global Success: Our Journey
From Humble Beginnings to Global Success: Our Journey Received order worth $ Received order in 2018 16.3 Mn for female worth $17 Mn and $6 Mn Commenced IVD condoms from National in 2020 for female Device Commercial production Cupid’s female condom department of Health condoms from Ministry manufactu
Slide 9: Global Reach: Our Product Presence Across The World
Global Reach: Our Product Presence Across The World South Africa Kenya Rwanda Zimbabwe Netherlands Switzerland Haiti Trinidad Brazil Indonesia Denmark Burma Ghana Nigeria Gabon Benin UAE Ivory Coast Uganda Nepal Srilanka Congo USA Syria Jamaica Belarus New Zealand Australia Ecuador Cameroon Albania
Slide 10: Technical Capabilities And Quality Practices
Technical Capabilities And Quality Practices Housed with Richter-Hi Tech German dipping technology World Class manufacturing facility in conformity with global and online electronic testing. So, every unit produced is standards and best quality practices electronically tested before dispatch Establi
Slide 11: In-house Laboratory: Equipped For Comprehensive Quality Testing
In-house Laboratory: Equipped For Comprehensive Quality Testing WELL EQUIPPED IN-HOUSE LABORATORY WITH TRAINED AND EXPERIENCED PERSONNEL TO CONDUCT BELOW TESTING o In-coming Raw & Packaging material testing o In-process product testing o Finished product testing: Burst Volume & Visual Dimensions Bur
Slide 12: Setting The Bar High: Our Quality Standard Certifications
Setting The Bar High: Our Quality Standard Certifications ISO 9001:2015 ISO 13485:2016 ISO 14001:2015 CE 2460 UNFPA- SABS MARK USFDA (510K) FOR BRAZIL ANVISA PREQUALIFICATION MALE CONDOMS Cupid Limited 11
Slide 13: World-Class Manufacturing Facility with German Dipping Technology
World-Class Manufacturing Facility with German Dipping Technology and Electronic Testing Manufacturing unit in Sinnar, Nashik about 200 km, East of Mumbai. 210Mn Sachets 24Mn Pieces 1,00,000 Sq. Ft 480 Mn Pieces 52 Mn Pieces Per Year Per Year Male condom Female condom Area Annual capacity Lubricant
Slide 14: Powering Our Business: Our Strong In-House Manufacturing Capabilities
Powering Our Business: Our Strong In-House Manufacturing Capabilities IVD SECTION DIPPING SECTION TESTING SECTION SEALING SECTION IVD SECTION FEMALE CONDOM SECTION LUBRICANT JELLY SECTION QUALITY TESTING LAB SECTION Cupid Limited 13
Slide 15: Cupid's Social Media Presence
Cupid's Social Media Presence Cupid Limited 14
Slide 16: Business Overview
Business Overview
Slide 17: Overview Of Our Product Portfolio
Overview Of Our Product Portfolio MALE CONDOMS FEMALE CONDOMS LUBRICANT JELLY IN VITRO DIAGNOSTIC DEVICE o Extra Large Condoms o Made up of Latex o Water based Lubricant jelly is o Foray into medical devices o Extra Strong Condoms o 100% Indian made and costs to be used with condoms to which include
Slide 18: Overview Of Our Product Portfolio: Male Condoms
Overview Of Our Product Portfolio MALE CONDOMS SIZES : Rectangular, Square & Circular format. TYPES : Plain, Dotted, Ribbed, Multi-textured, Extra Strong, Extra Large & Ultra-Thin. INSTALLED CAPACITY OF 480 MILLION Male Condoms are available in different varieties like Plain, Dotted, Ribbed, Multi-t
Slide 19: Overview Of Our Product Portfolio: Female Condoms and Lubricant Jelly
Overview Of Our Product Portfolio FEMALE CONDOMS LUBRICANT JELLY o Water based Lubricant Jelly is used with condoms to enhance pleasure. Cupid Limited started manufacturing lubricant jelly in 2015. o Water based Lubricants are available in different pack sizes starting from 4.5ml sachets, Laminated
Slide 20: Overview Of Our Product Portfolio: In Vitro Diagnostic Device
Overview Of Our Product Portfolio IN VITRO DIAGNOSTIC DEVICE Syphilis Ab Test HIV 1 & 2 Ab Test Viral Transport Medium o Chromatographic immunoassay o Chromatographic immunoassay o Intended use: for the collection o Detection of Specific TP o Detection of HIV 1 & 2 antibodies and transport of clinic
Slide 21: Overview Of Our Product Portfolio: In Vitro Diagnostic Device
Overview Of Our Product Portfolio IN VITRO DIAGNOSTIC DEVICE Malaria Pf-Pv Ag Test Hepatitis C (HCV) Ab Test Pregnancy HCG Detection Test o Chromatographic immunoassay o Chromatographic immunoassay o Chromatographic immunoassay o Detection of Pf-HRP II and Pv- o Detection of HCV antibodies o Detecti
Slide 22: Management Overview
Management Overview
Slide 23: Core Management Team
Core Management Team Mr. Omprakash Garg Mrs. Veena Garg Mr. Suresh Chand Garg Mr. Jandhyala L. Sharma Managing Director And Chairman Non Executive Director Non Executive Director Independent Director o He is a promoter of the Company o She belongs to promoter group. o He belongs to promoter group. o
Slide 24: Professional & Experienced Management
Professional & Experienced Management Mr. Sunil Surekha Ms. Nalini Mishra Mr. Narendra Joshi Mr. Saurabh Karmase Independent Director Independent Director Chief Financial Officer Company Secretary & Compliance Officer o Education – Chartered Accountant o She has more than a decade of o He has an exp
Slide 25: Industry Overview
Industry Overview
Slide 26: Industry Overview: Global Market
Industry Overview GLOBAL MARKET The global condom market size was valued at USD 10.7 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.57% from 2023 to 2030 The condom product market is divided into male and 01 06 The female condom segment is estimated to witness
Slide 27: Global Growth Drivers
Global Growth Drivers GLOBAL CONDOM MARKET Share, by region, 2022 (%) Rising awareness The availability of regarding the use of different types of condoms. condoms to suit consumer needs 1 2 Measures to reduce the The free distribution of spread of HIV and other condoms by STIs government North Amer
Slide 28: India's Condom Market: Trends And Opportunities For Growth
India’s Condom Market: Trends And Opportunities For Growth o The Indian Condom market is expected to reach US$ 508.36 Mn in 2027 from US$ 183.46 Mn in 2018. o The market is estimated to grow with a CAGR of 12.2% from 2019-2027. o North Zone is expected to lead the market in the India owing to the re
Slide 29: Financial Overview
Financial Overview
Slide 30: Q4 FY23 Standalone Results Highlights
Q4 FY23 Standalone Results Highlights In ₹ Cr Particulars Q4 FY23 Q4 FY22 Y-O-Y % FY23 FY22 Y-O-Y % Net Sales 41.50 31.36 159.33 132.73 Other Income 1.99 1.06 4.77 4.31 Total Income 43.49 32.42 34.10% 164.10 137.04 19.75% Raw Material Costs 18.27 15.43 65.01 61.99 Employee Cost 4.89 2.48 13.77 10.91
Slide 31: Q4 FY23 Standalone Results Highlights
Q4 FY23 Standalone Results Highlights Total Income In ₹ Cr EBITDA PAT In ₹ Cr EBITDA Margin PAT Margin In % 43.49 10.60 25.54 8.34 20.88 20.09 32.43 6.55 13.35 4.19 Q4 FY22 Q4 FY23 Q4 FY22 Q4 FY23 Q4 FY22 Q4 FY23 Cupid Limited 30
Slide 32: Q4 FY23 Revenue Analysis
Q4 FY23 Revenue Analysis Geography Wise Sales Breakup Product Wise Sales Breakup In % In % 8 3 15 Male Condom Domestic Female Condom Exports Lubricant Jelly 82 92 Cupid Limited 31
Slide 33: Last 3 Years Standalone Financial Highlights
Last 3 Years Standalone Financial Highlights Total Income In ₹ Cr EBITDA PAT In ₹ Cr EBITDA Margin PAT Margin In % 41.19 41.31 164.10 28.66 25.93 31.58 28.98 148.90 20.16 19.82 22.99 17.32 17.28 13.02 137.04 FY21 FY22 FY23 FY21 FY22 FY23 FY21 FY22 FY23 Cupid Limited 32
Slide 34: Standalone Profit & Loss Statement
Standalone Profit & Loss Statement In ₹ Cr Particulars FY21 FY22 FY23 Net Sales 143.73 132.73 159.33 Other Income 5.17 4.31 4.77 Total Income 148.90 137.04 164.10 Expenses 0.00 0.00 0.00 Raw Material Costs 50.47 61.99 65.01 Employee Cost 10.14 10.91 13.77 Other Expenses 47.10 36.84 39.24 Total Expen
Slide 35: Last 3 Years Standalone Financial Highlights
Last 3 Years Standalone Financial Highlights In ₹ Cr Equities & Liabilities FY21 FY22 FY23 Assets FY21 FY22 FY23 Equity 13.34 13.34 13.34 Non Current Assets Reserves 117.51 128.85 153.78 Fixed Assets 30.53 36.52 36.06 Net Worth 130.85 142.19 167.12 Non Current Investment 0.00 0.00 0.00 Non Current L
Slide 36: FY23 Revenue Analysis
FY23 Revenue Analysis Geography Wise Sales Breakup In % Product Wise Sales Breakup In % 6 9 16 Male Condom Domestic Female Condom Exports Lubricant Jelly 75 94 Cupid Limited 35
Slide 37: Stock Data
Stock Data Stock Information Share Holding Pattern As on 26-05-2023 As on 31-3-2023 BSE Code 530843 NSE Code CUPID Bloomberg CUPD-IN ISIN INE509F01011 Promoters Share Price ₹ 267.70 45.06% Market Capitalization ₹ Cr 357.06 No. of Share Outstanding 1,33,38,000 54.94% Public Face Value ₹ 10 52 Week Hi
Slide 38: Thank You
CUPID Limited A-68, MIDC, Sinnar, Nashik-422113 Email: info@cupidlimited.com Website: www.cupidlimited.com Phone: 02551-230280 Kirin Advisors Private Limited 713-B, Lodha Supremus II, Wagle Estate, Thane West – 400 604. Email: info@kirinadvisors.com Website: www.kirinadvisors.com Thank You Phone: 02